Nathan Clendenen, MD, MS
Chicago—Transitioning to a dexmedetomidine-based sedation strategy should decrease mortality rates in post–cardiac surgery patients, according to a new study, and delirium in patients receiving dexmedetomidine was also found to be reduced.
“At our institution, we use dexmedetomidine as the first-line sedative medication for patients in the CTICU [cardiothoracic ICU] because we have noted that it provides excellent sedation with minimal side